Advertisements

Metocal Vit D3

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Metocal Vit D3

Metocal Vit D3 is defined as an oral solid combination product formulated to manage the body's mineral balance by supplying calcium and regulating its absorption. This medication provides a dual-action approach, delivering the essential mineral necessary for cellular function while simultaneously activating the regulatory mechanisms required for its proper utilization.

Property Description
Active Ingredients Calcium Carbonate, Dihydrotachysterol (DHT)
Form Oral Solid Preparation (e.g., tablet/capsule)
Pharmacological Class Calcium and Vitamin D Analogues (ATC A11CC)
General Purpose Supporting Calcium Homeostasis and Skeletal Health
Origin Mineral Salt combined with a Synthetic Analogue

What Type of Medicine is Metocal Vit D3?

Metocal Vit D3 is a combination product classified pharmacologically under Calcium and Vitamin D Analogues, clinically recognized for its role as an agent for calcium homeostasis regulation. Its purpose is to influence the concentrations of calcium and phosphate in the body, primarily to support the structural integrity of the skeletal system. The medication is presented as an oral solid preparation, a form preferred for consistent internal administration. While Metocal Vit D3 is one specific brand, the combination of Calcium Carbonate and Dihydrotachysterol is a well-established formulation, with similar products sometimes marketed under names such as Hytakerol.

Calcium Carbonate and Dihydrotachysterol: A Combination Product

The drug entity contains two active ingredients: Calcium Carbonate and Dihydrotachysterol (DHT). Calcium Carbonate serves as a direct source of elemental calcium, the fundamental component for bone tissue. Dihydrotachysterol is a potent, synthetic analogue of Vitamin D, chemically distinct as a reduction product of ergocalciferol. This combination ensures not only the supply of the mineral but also the immediate availability of a powerful regulating compound, which is pharmacologically advantageous for managing impaired calcium metabolism.

General Purpose: Supporting Calcium Homeostasis

The primary benefit of Metocal Vit D3 is to restore and maintain adequate serum calcium levels throughout the body, a vital process known as calcium homeostasis. Maintaining appropriate calcium balance is critical for numerous physiological processes beyond bone health, including nerve signaling and muscle contraction. This mechanism of action, supported by the combination of mineral supply and analogue regulation, provides foundational support for overall mineral balance and function.

Regulatory References

  1. ATC A11CC
Advertisements

What side effects are possible with Metocal Vit D3?

Possible Side Effects and Safety Information

Adverse Reaction Scope

The most significant safety concern associated with Metocal Vit D3 (cholecalciferol) is the risk of Hypercalcemia (abnormally high blood calcium levels), which is typically dose-related, occurring with excessive or chronic high-dose intake. The main system-organ classes involved in adverse reactions are Metabolism and Nutrition Disorders (hypercalcemia, hypervitaminosis D), Renal and Urinary Disorders (hypercalciuria, nephrolithiasis, nephrocalcinosis), and Gastrointestinal Disorders (nausea, constipation, vomiting, abdominal pain).

Serious adverse reactions directly linked to severe hypercalcemia include Nephrocalcinosis (calcification of the kidneys), Nephrolithiasis (kidney stones), and potential severe cardiac arrhythmias. Symptoms of early overdose, which may signal the onset of serious effects, include weakness, a metallic taste, weight loss, and bone pain. Allergic reactions, though uncommon, are also possible.

Safety Considerations and Restrictions

Contraindications for use include known hypersensitivity to Vitamin D, pre-existing Hypercalcemia, Hypervitaminosis D, and any condition causing significant Malabsorption. Caution and careful monitoring are required for patients with kidney disease, conditions affecting calcium regulation such as Sarcoidosis or Hyperparathyroidism, and those with a history of kidney stones.

Population-Specific Safety: High doses, typically exceeding 4,000 IU daily, are considered possibly unsafe during pregnancy and breast-feeding due to the risk of fetal and infant harm from persistent hypercalcemia. For certain high-dose formulations, regulatory agencies have often restricted use in children and adolescents below 18 years of age due to potential developmental risks.

Monitoring: Official regulatory guidance recommends routine monitoring of serum calcium, urinary calcium, and creatinine concentrations during high-dose or long-term therapy to prevent hypercalcemia and associated renal complications.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The overdose profile for Metocal Vit D3 (Calcium Carbonate and Dihydrotachysterol) is defined by the risk of Hypervitaminosis D and resulting severe Hypercalcemia, as documented in government regulatory sources.

Documented Overdose Manifestations

System Official Regulatory Findings
Gastrointestinal Nausea, vomiting, loss of appetite (anorexia), abdominal cramps, constipation.
Systemic/Renal Excessive thirst (polydipsia), increased urination (polyuria, nocturia), unusual weakness, muscle pain.

Overdose may lead to severe outcomes that include cardiac arrhythmias, high blood pressure, and progression to serious renal insufficiency. Central Nervous System effects, such as mental confusion and seizures, are also documented complications.

Required Emergency Action

Regulatory documents mandate specific immediate action for suspected overdose:

  • Seek immediate medical attention or contact a Poison Control Center immediately.
  • Stop using the medication at once upon suspicion of overdose or the onset of severe symptoms (e.g., uneven heartbeats, mental confusion, or severe gastrointestinal distress).

Management in these situations requires symptomatic and supportive treatment to reverse hypercalcemia. Monitoring requirements include frequent checks of serum electrolyte concentrations and cardiac function, especially in patients with existing renal impairment, where risks are increased.

Advertisements

Therapeutic Uses of Metocal Vit D3

What Metocal Vit D3 Treats: Main Uses and Benefits

Metocal Vit D3 (Calcium Carbonate and Cholecalciferol) is commonly used to help with the prevention and treatment of deficiencies, to provide support for skeletal health, and as an adjunct to specific management for osteoporosis.

The medicine is considered relevant in areas where short-term symptom management is appropriate, such as symptoms related to physical discomfort and in conditions where functional stability becomes affected. When symptoms intensify and supportive relief is needed, this supplement is relevant for easing symptoms that interfere with daily functioning. It supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load.


Supportive Management Domains

Addressing Symptom Clusters in Bone and Muscle Discomfort

This medication plays a role in easing the overall symptom burden, which contributes to improved comfort during periods of heightened symptoms. It helps maintain a sense of stability when symptoms are more noticeable and provides supportive relief when symptoms interfere with routine activities.


Easing Discomfort in Patients Requiring Additional Symptom Support

Used in scenarios where additional management of discomfort is required, it may help patients cope more steadily with symptom fluctuations.

Quick Fact: Support for Symptomatic Discomfort

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Metocal Vit D3?

Eligibility for Metocal Vit D3 (Calcium Carbonate and Dihydrotachysterol) is strictly defined by regulatory documents, focusing on existing mineral balance and organ function. This medicine is primarily intended for Adults requiring management of calcium homeostasis, such as those with Hypoparathyroidism or Renal Osteodystrophy.

Use is strictly Contraindicated in individuals with a current state of Hypercalcaemia (high blood calcium levels), Hypervitaminosis D (vitamin D overdosage), or Hypersensitivity to any of the product components. Individuals with severe renal failure or certain diseases that cause high calcium levels, such as sarcoidosis, must not use this product.

Use is restricted for specific populations. The combination product is often not indicated for use in pediatric patients (children under a specific age). Patients with mild to moderate renal impairment or a history of renal stones require conditional use and close professional supervision, which typically involves mandatory monitoring of serum and urinary calcium levels. Use during pregnancy and lactation must also be medically directed and is restricted by official regulatory guidance.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Metocal Vit D3, a combination product of Calcium Carbonate and Dihydrotachysterol (a Vitamin D analogue), has officially documented interactions that primarily involve two mechanisms: additive effects on systemic calcium levels and impaired absorption of co-administered substances.

Pharmacodynamic and Contraindicated Interactions

Co-administration with Other Vitamin D Analogues is restricted due to the increased risk of additive adverse effects and hypercalcaemia. Concomitant use with Thiazide Diuretics increases the risk of hypercalcaemia because these medicines reduce the urinary excretion of calcium. The combination with Cardiac Glycosides carries an official risk of increased cardiac toxicity, necessitating mandatory monitoring.

Interacting Substance/Class Official Interaction Outcome Mandatory Separation Rule
Tetracycline Preparations Decreased antibiotic absorption Administer 2 hours before or 4–6 hours after
Quinolone Antibiotics, Iron, Zinc Decreased absorption of co-administered drug Administer 2 hours before or after
Levothyroxine Reduced efficacy of thyroid hormone Administer at least 4 hours apart

The absorption-reducing effect of calcium salts requires explicit timing-based administration rules for agents like Bisphosphonates, which must be taken at least three hours prior to calcium intake. Furthermore, the label notes that the calcium component's absorption is inhibited by dietary Oxalic Acid (in spinach/rhubarb) and Phytic Acid (in whole cereals), requiring these to be avoided within two hours of intake. Patients with Impaired Renal Function are a population noted to have an increased risk of hypercalcaemia during therapy.

Advertisements

Mechanism of Action

Metocal Vit D3 (cholecalciferol precursor) is converted by the body into the active secosteroid hormone, calcitriol (1,25( OH)2 D3). Calcitriol functions to regulate mineral concentration and acts via the nuclear Vitamin D Receptor (VDR) to modulate gene expression across various systems.

VDR-Mediated Genomic Signaling

This process involves calcitriol binding to the VDR, forming a complex that directly influences gene transcription (genomic signaling). This action regulates the expression of genes responsible for calcium and phosphate transport, which modulates processes contributing to mineral concentration regulation.

Modulation of Intestinal Mineral Absorption

This mechanism acts on the epithelial cells of the small intestine by increasing the production of transport proteins, such as Calbindin. This facilitated transport enhances the uptake of dietary calcium and phosphate into the bloodstream, increasing the availability of these ions for skeletal processes.

Negative Feedback on Parathyroid Hormone (PTH)

Calcitriol acts on the parathyroid glands, where it inhibits the gene expression of Parathyroid Hormone (PTH). This action provides a negative feedback signal, modulating the PTH-mediated influence on skeletal mineral stores.

Advertisements

Dosage and Administration Information

How Metocal Vit D3 is Used: Official Administration and Dosing

Metocal Vit D3 (Calcium Carbonate and Dihydrotachysterol) is administered based on official prescribing information that dictates a strict protocol for use, focusing on the route, dose, and frequency, without addressing therapeutic outcomes or safety.


Official Administration Protocol

The approved and sole route of administration for Metocal Vit D3 is oral, consistent with its formulation as an oral solid preparation.

Component Administration Detail
Route of Administration Oral only (ingestion)
Dosing Frequency Dihydrotachysterol (DHT) is taken once daily. The Calcium component is often administered in multiple divided doses throughout the day.
Timing & Preparation Calcium Carbonate intake is often recommended with food to optimize absorption. Chewable forms must be fully chewed.

Standard Dosing and Adjustments

Dosage is highly individualized and managed in two phases: an initial correction phase followed by long-term maintenance. The regimen is primarily guided by the Dihydrotachysterol component's instructions.

  • Adult Dosing (DHT): The typical initial dose is 0.8 mg to 2.4 mg once daily for several days. This transitions to a maintenance dose range of 0.2 mg to 1.0 mg once daily.
  • Calcium Requirement: Therapy must include adequate elemental calcium supplementation, typically 1 to 2 grams daily, often provided by the Calcium Carbonate component.
  • Pediatric Rules: Specific pediatric regimens exist for the Dihydrotachysterol component, including defined starting and maintenance doses for neonates, infants, and children.

Required Procedural Constraints

Use requires mandatory medical oversight. The dosage is adjusted based on frequent serum calcium level monitoring (e.g., weekly during initial therapy), with the goal of maintaining levels between 9 to 10 mg/100 mL. The product must be withheld if hypercalcemia is detected, as per standard clinical protocols.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence: Metocal Vit D3

Clinical research has focused on assessing the impact of combined Calcium and Vitamin D3 supplementation, such as that provided by Metocal Vit D3, primarily on bone health outcomes.

Studies on Bone Mineral Density (BMD)

Evidence from systematic reviews and meta-analyses examined the effect of long-term supplementation on Bone Mineral Density in older adults and postmenopausal women. The findings indicated that consistent intake of both calcium and cholecalciferol (Vitamin D3) was associated with the maintenance or a statistically non-significant increase in BMD at key skeletal sites, including the lumbar spine and femoral neck, when compared to placebo or low-intake controls.

Evidence Related to Fracture Risk

Controlled trials have evaluated the primary outcome of fracture incidence. Research suggests that daily co-administration of Calcium and Vitamin D3 may be related to a reduced risk of non-vertebral fractures, particularly in individuals with documented Vitamin D deficiency or very low baseline calcium intake. However, evidence remains mixed when evaluating fracture risk reduction across all elderly populations without deficiency, suggesting that the effectiveness may depend heavily on the patient's nutritional baseline.

Safety and Tolerability Profile

The overall safety profile was assessed in large-scale studies. The most frequently reported adverse events related to supplementation included gastrointestinal discomfort, such as constipation and flatulence. Researchers also tracked the incidence of hypercalcemia (abnormally high calcium levels) and hypercalciuria (excess calcium in the urine). The measured incidence of these events was low when the prescribed intake limits were followed.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Metocal Vit D3 (FAQ)


Q: Is Metocal Vit D3 the same as just taking a standard Vitamin D supplement?

According to official drug classification, Metocal Vit D3 is a combination product. It supplies Calcium Carbonate and Dihydrotachysterol, which is chemically defined as a synthetic analogue of Vitamin D. This is different from taking a standard Vitamin D (cholecalciferol) supplement alone.


Q: What is the difference between Metocal Vit D3 and other calcium supplements?

Metocal Vit D3 is a dual-action agent because it provides both the mineral, Calcium Carbonate, and a Vitamin D analogue (Dihydrotachysterol). Many common calcium supplements contain only the calcium component. The inclusion of the analogue is intended to regulate the absorption and metabolism of the mineral, according to the drug’s class.


Q: Can Metocal Vit D3 be crushed or chewed?

Official administration rules indicate that if the product is a chewable form, it is intended to be fully chewed to support proper absorption. Information regarding crushing or altering non-chewable forms is specified on the specific product label.


Q: Is it okay to take other vitamin supplements while using Metocal Vit D3?

Official interactions documentation focuses on other Vitamin D analogues and certain medications. The full interactions profile of the specific product contains details regarding co-administration with other substances and is available in regulatory documents.


Q: Can Metocal Vit D3 affect my blood test results?

Yes, regulatory guidance requires mandatory and frequent monitoring of specific blood parameters, such as serum calcium levels, during treatment. This is because the medicine is designed to affect and regulate these mineral concentrations in the bloodstream.


Q: Is there a specific time of day Metocal Vit D3 is usually suggested to be taken?

The official guidance notes that the Calcium Carbonate component is often recommended to be taken with food to achieve optimal absorption. The recommendation to take it with food is intended to optimize absorption.


Q: How quickly is Metocal Vit D3 expected to start working?

The onset of the full therapeutic effect is a gradual process that is managed through an initial correction phase followed by a maintenance phase. This process is managed by frequent monitoring of serum calcium levels, as described in procedural guidelines.


Q: Does Metocal Vit D3 carry a Black Box Warning?

While the term 'Black Box Warning' may not be present on every country's label, official labeling prominently details serious risks associated with the drug. These warnings detail the serious risk of Hypercalcemia (abnormally high calcium levels) and related severe side effects like kidney calcification.


Q: Is it common to feel stomach upset after starting Metocal Vit D3?

Yes, official safety profiles and clinical studies list gastrointestinal discomfort as one of the frequently reported adverse events. This can include symptoms such as flatulence, nausea, vomiting, or constipation.


Q: Does Metocal Vit D3 contain lactose or gluten?

The presence or absence of specific inactive ingredients like lactose, gluten, or sugars is contained within the official product documentation. The full list of excipients, or inactive components, is specified in the Summary of Product Characteristics (SmPC) or the FDA DailyMed label.


Q: Can Metocal Vit D3 be used by individuals who are vegetarian or vegan?

Reviewing the official Excipients list in the product's regulatory documentation can indicate the presence or absence of animal-derived ingredients, such as gelatin or specific coatings, which is relevant for vegetarian or vegan use.


Q: Can Metocal Vit D3 be taken by children?

Official restrictions state that the product is often not indicated for use in pediatric patients. Furthermore, regulatory guidance may restrict the use of high-dose formulations in adolescents below 18 years of age due to potential developmental risks.


Q: How long does the effect of Metocal Vit D3 last in the body?

The duration of the drug's activity in the body is informed by the officially documented pharmacology of its active components. Specifically, the half-life of Dihydrotachysterol and its major metabolite is established in pharmacology resources.


Q: Does Metocal Vit D3 contain any sugar or artificial sweeteners?

The official product documentation, such as the Summary of Product Characteristics (SmPC), contains a complete list of all inactive ingredients. This list specifies the presence or absence of components like sugars or artificial sweeteners.


Q: What happens if Metocal Vit D3 is taken with milk or dairy products?

The regulatory label notes that absorption of the calcium component can be inhibited by specific food substances, such as oxalic and phytic acid. Taking the medicine alongside high-calcium dairy products may necessitate the adjustment of intake timing or monitoring of total calcium intake, as detailed in product information.


Q: Can Metocal Vit D3 impact my mood or mental health?

Official adverse event information does not typically list mood changes as a common effect at therapeutic doses. However, symptoms of an overdose, such as Hypercalcemia, can lead to central nervous system effects including confusion and fatigue.


Q: Does Metocal Vit D3 have any warnings about driving or operating machinery?

Yes, official product information, such as the Summary of Product Characteristics (SmPC), includes a section that addresses the potential effects of the medicine on the ability to drive and safely operate machinery.


Q: Is there evidence for Metocal Vit D3 beyond bone health?

Official documents define the drug's purpose as supporting general calcium homeostasis, which is the regulation of calcium levels throughout the body. This process is noted to be critical for physiological functions beyond skeletal structure, including nerve signaling and muscle contraction.


Q: Does taking Metocal Vit D3 help with general fatigue?

Fatigue or weakness is officially listed as a symptom of early overdose (Hypercalcemia), not as a known therapeutic effect of the drug. Its intended use is to regulate calcium and phosphate levels in the body.


Q: Are there reports of long-term problems from using Metocal Vit D3?

Official guidance warns of specific risks associated with long-term therapy, primarily the need for monitoring to prevent renal complications. The documented long-term risks include potential kidney problems such as nephrocalcinosis and nephrolithiasis (kidney stones).


Q: Is Metocal Vit D3 available without a prescription?

The availability of Metocal Vit D3 is determined by its official regulatory status. Government drug records specify whether the product is classified as a prescription-only (Rx) medicine or an over-the-counter (OTC) product.


Q: Why does Metocal Vit D3 come in different forms or strengths?

Official dosing guidelines explain that treatment is highly individualized and is managed in two phases: an initial correction phase and a long-term maintenance phase. This structured and individualized approach requires a range of available forms and strengths to accommodate different patient needs and dosage adjustments.


Q: Can Metocal Vit D3 be used for prevention of certain conditions?

Official documentation defines the primary uses of the drug. Clinical evidence referenced in official documents suggests that co-administration of Calcium and Vitamin D may be related to a reduced risk of non-vertebral fractures in certain patient populations.

Advertisements

How should Metocal Vit D3 be stored and disposed of?

Storage Conditions

Metocal Vit D3 (Calcium Carbonate and Dihydrotachysterol) must be stored under Controlled Room Temperature conditions, generally not exceeding 25 C. The medicine must be kept in its original container, which must be tightly closed to maintain product quality.

Protection from environmental factors is mandatory: the product must be stored in a dry place and protected from light to prevent the degradation of its active components. It is strictly required to keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Metocal Vit D3 must not be disposed of in household waste or flushed down toilets or drains. Disposal must be conducted in accordance with local regulations by utilizing a specific drug take-back program or a licensed pharmaceutical waste service, as designated by government authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Metocal Vit D3 found in:

A-Z Index: